<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">Cardiovascular diseases</z:e> are the major cause of mortality in patients with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Monocyte chemoattractant protein-1 (<z:chebi fb="17" ids="50099">MCP</z:chebi>-1) is a potent chemokine and plays an important role in <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The objective of this study was to evaluate the relation between the genotypes of the <z:chebi fb="17" ids="50099">MCP</z:chebi>-1 A-2518G polymorphism and the development of carotid <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: The subjects were 303 unrelated patients who were diagnosed with type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>To evaluate <z:e sem="disease" ids="C1096293" disease_type="Disease or Syndrome" abbrv="">macroangiopathy</z:e>, we measured carotid artery intima-media thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>) by ultrasonography </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:chebi fb="17" ids="50099">MCP</z:chebi>-1 A-2518G polymorphism was determined by TaqMan PCR method </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> in patients with the <z:chebi fb="17" ids="50099">MCP</z:chebi>-1 -2518 AG or GG genotype was significantly greater than the AA-genotype (P=0.007) </plain></SENT>
<SENT sid="7" pm="."><plain>Simple regression analysis showed that age, systolic blood pressure, <z:chebi fb="1" ids="47774">LDL-cholesterol</z:chebi>, the <z:chebi fb="17" ids="50099">MCP</z:chebi>-1 -2518 AG+GG polymorphism, and HbA1c level were correlated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> (P&lt;0.0001, &lt;0.0001, 0.006, 0.007, 0.025, respectively) </plain></SENT>
<SENT sid="8" pm="."><plain>In multiple regression analysis, the <z:chebi fb="17" ids="50099">MCP</z:chebi>-1 -2518 AG+GG polymorphism was the third strongest independent determinant of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (P=0.021), subsequent to age and systolic blood pressure </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Assessment of the <z:chebi fb="17" ids="50099">MCP</z:chebi>-1 A-2518G polymorphism would be useful in identifying the risk of developing carotid <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>